[Abstract] In this protocol, engineered Cas9-ribonucleoprotein (Cas9 protein and sgRNA, together called Cas9-RNP) and gold nanoparticles are used to make nanoassemblies that are employed to deliver Cas9-RNP into cell cytoplasm and nucleus. Cas9 protein is engineered with an N-terminus glutamic acid tag (E-tag or En, where n = the number of glutamic acid in an E-tag and usually n = 15 or 20), C-terminus nuclear localizing signal (NLS), and a C-terminus 6xHis-tag. [Cas9En hereafter] To use this protocol, the first step is to generate the required materials (gold nanoparticles, recombinant Cas9En, and sgRNA). Laboratory-synthesis of gold nanoparticles can take up to a few weeks, but can be synthesized in large batches that can be used for many years without compromising the quality. Cas9En can be cloned from a regular SpCas9 gene (Addgene plasmid id = 47327), and expressed and purified using standard laboratory procedures which are not a part of this protocol.
Nanoparticles, Gene editing
[Background] Delivery of Cas9-ribonucleoprotein provides an alternative strategy for CRISPR gene delivery, offering a transient way of editing genes. Although a few strategies for Cas9-RNP delivery have been reported, these strategies suffer from endosomal entrapment of both Cas9 protein and sgRNA . Mechanical methods including membrane deformation (Han et al., 2015) , electroporation (Schumann et al., 2015) , and the use of hypertonic agents (D'Astolfo et al., 2015) provide direct delivery, however, they require specialized instrumentations and are generally not practical for in vivo therapeutic applications. Our protocol provides an approach for direct cytoplasmic and nuclear delivery of Cas9-RNP that can find applications in both gene editing and genome imaging. Final working nanoassembly concentration is 125 nM of ArgNPs and 62 nM of Cas9En-RNP complex, which is at a 2:1 molar ratio of ArgNPs/Cas9En-RNP. The total volume of the nanoassembly samples required for delivery depends on the kind of cell culture plate used. We www.bio-protocol.org/e2586 -10 x 10 5 cells/well.
2. On the day of delivery, prepare the Cas9En-RNP complex by simply mixing Cas9En and sgRNA at a 1:1 molar ratio in 10-20 μl of 1x PBS buffer. Keep in mind that the final Cas9En-RNP concentration in 500 μl sample should be 62 nM (~5 μg Cas9En, and 1 μg sgRNA).
3. Incubate the complex at room temperature for 30 min.
4. In the meantime, add 100 μl of 1x PBS into a sterile 1.5 ml tube.
Add required amount of ArgNPs into the tube containing 1x PBS to make the final concentration
of ArgNPs 125 nM for 500 μl sample. Mix by pipetting up and down.
6. Now add the premixed Cas9En-RNP complex to the ArgNPs solution in the tube.
7. Mix well by pipetting up and down.
8. Incubate the sample at room temperature for 10 min. The nanoassemblies will be ready in 10 min and therefore users should prepare the cells for delivery in the meantime.
Note: Don't incubate for more than 10 min, as this may cause aggregate formation instead of
well-defined assemblies.
9. Wash the cells with 1x PBS, twice.
10. When the nanoassembly sample is ready after 10 min, add ~400 μl of DMEM plain media (or any media of interest) into the nanoassembly solution in the tube. Mix well.
Note: Media with serum should be strictly avoided at this step; media with serum may require further optimization such as the ratio of nanoparticles to Cas9En:sgRNA, and incubation time.
11. Add the whole (500 μl) sample into the washed-cells.
12. Incubate the cells at an appropriate condition (usually 5% CO2 and 37 °C) for 3 h. Complete
Cas9En-RNP delivery should be achieved after 3 h of incubation.
13. Wash away the media after 3 h, and replace with fresh desired media (DMEM with 10% serum and 1% antibiotics, and any supplements if needed).
Data analysis
Cytoplasmic delivery efficiency of Cas9En or Cas9En-RNP was determined by confocal microscopy imaging. Even distribution of fluorophore labelled Cas9En in the cytosol and nucleus is considered as effective delivery, whereas any punctate distribution in the cytoplasm is considered as endosomal delivery (Figures 2A and 2B) . Briefly, ~400 cells were counted manually to estimate effective cytosolic and nuclear delivery. Any punctate distribution (see Figure 2B ) of labelled-Cas9En should www.bio-protocol.org/e2586 3. Freshly prepared (not more than a week old, and preserved at 4 °C) Cas9En should be used for better activity. Flash-frozen Cas9En at -80 °C with glycerol should be avoided as our preliminary investigation shows that glycerol hampers assembly formation.
